Results 1 - 7 from 7 for "bioeel"
-
Pharma Group Bioeel 1Q/2023 Turnover Rises 40% To over RON215M
05.31.2023
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in the first quarter of this year raked in turnover of above RON215 million (around more
-
Pharma Group Bioeel Expects RON710M Turnover in 2023, Up 3.5% YOY
03.06.2023
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, projects total turnover worth around RON710.6 million in 2023 (around EUR144 million) at more
-
Pharma Group Bioeel Ends 2022 with RON686M Turnover, Up 22% YOY
01.26.2023
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in 2022 generated turnover worth around RON686.4 million (EUR139.5 million) at group more
-
Pharma Group Bioeel Expects RON630M Turnover in 2022
12.23.2022
Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, estimates it will generate turnover of around RON630 million (EUR127.5 million) by more
-
Pharma Group Bioeel Sees 1H/2022 Turnover Rise by 21% To over RON312M
10.11.2022
Pharma group Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in the first half of this year generated turnover worth RON312 million more
-
Pharma Group Bioeel Bets on 7-8% Turnover Growth in 2022
03.22.2022
Pharma group Bioeel, owned by businessman Albert Attila, a founding member, and Jean Scheftsik de Szolnok, a French citizen, expects 7-8% turnover growth at group level for 2022 on the year. more
-
Pharma Group Bioeel Hits RON562M Turnover in 2021, Up 18% YOY
02.22.2022
Pharma group Bioeel, owned by businessman Albert Attila, a founding member, and Jean Scheftsik de Szolnok, a French citizen, in 2021 generated turnover worth RON562 million (EUR114.2 million), 18% more